journal article·2024-11Open access

A functional analysis of a resorbable citrate-based composite tendon anchor

Arun Thirumaran, Meletios-Nikolaos Doulgkeroglou, Magesh Sankar, Jeremiah T. Easley, Ben Gadomski, Anup Poudel, Manus Biggs

Abstract

Rapid and efficient tendon fixation to a bone following trauma or in response to degenerative processes can be facilitated using a tendon anchoring device. Osteomimetic biomaterials, and in particular, bio-resorbable polymer composites designed to match the mineral phase content of native bone, have been shown to exhibit osteoinductive and osteoconductive properties in vivo and have been used in bone fixation for the past 2 decades. In this study, a resorbable, bioactive, and mechanically robust citrate-based composite formulated from poly(octamethylene citrate) (POC) and hydroxyapatite (HA) (POC-HA) was investigated as a potential tendon-fixation biomaterial. In vitro analysis with human Mesenchymal Stem Cells (hMSCs) indicated that POC-HA composite materials supported cell adhesion, growth, and proliferation and increased calcium deposition, alkaline phosphatase production, the expression of osteogenic specific genes, and activation of canonical pathways leading to osteoinduction and osteoconduction. Further , in vivo evaluation of a POC-HA tendon fixation device in a sheep metaphyseal model indicates the regenerative and remodeling potential of this citrate-based composite material. Together, this study presents a comprehensive in vitro and in vivo analysis of the functional response to a citrate-derived composite tendon anchor and indicates that citrate-based HA composites offer improved mechanical and osteogenic properties relative to commonly used resorbable tendon anchor devices formulated from poly(L- co -D, l -lactic acid) and tricalcium phosphate PLDLA-TCP. In this manuscript, we describe a resorbable, bioactive, and mechanically robust citrate-based composite, formulated from poly(octamethylene citrate) (POC) and hydroxyapatite (HA) (POC- HA) as a potential orthopedic biomaterial. In vitro analysis with human Mesenchymal Stem Cells (hMSCs) indicated that POC-HA composite materials supported cell adhesion, growth, and proliferation and increased calcium deposition, alkaline phosphatase production, the expression of osteogenic specific genes and activation of canonical pathways leading to osteoinduction and osteoconduction. Further in vivo evaluation of a POC-HA tendon fixation device in a sheep metaphyseal model indicated the regenerative and remodeling potential of this citrate-based composite material in orthopedic applications. Importantly, this study establishes the chemical foundations for a broad range of synthetic osteogenic biomaterials or scaffolds which can be formulated into resorbable orthopedic implants.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties · Facial Trauma and Fracture Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. Osteoinduction, osteoconduction and osseointegration
2. In vitro bone engineering based on polycaprolactone and polycaprolactone–tricalcium phosphate composites10.1002/pi.2138 ↗
3. Fabrication, mechanical and in vivo performance of polycaprolactone/tricalcium phosphate composite scaffolds10.1016/j.actbio.2012.05.018 ↗
4. Repair of large articular osteochondral defects using hybrid scaffolds and bone marrow-derived mesenchymal stem cells in a rabbit model10.1089/ten.2006.12.1539 ↗
5. A bone substitute composed of polymethylmethacrylate and α-tricalcium phosphate: results in terms of osteoblast function and bone tissue formation10.1016/S0142-9612(02)00196-5 ↗
6. Synthesis of macroporous hydroxyapatite scaffolds for bone tissue engineering10.1002/jbm.10163 ↗
7. Biomimetic mineralization on natural and synthetic polymers to prepare hybrid scaffolds for bone tissue engineering10.1016/j.colsurfb.2019.03.004 ↗
8. Poly (lactic acid)-based biomaterials for orthopaedic regenerative engineering10.1016/j.addr.2016.04.015 ↗
9. Load‐bearing biodegradable PCL‐PGA‐beta TCP scaffolds for bone tissue regeneration10.1002/jbm.b.34691 ↗
10. Fabrication of blended polycaprolactone/poly (lactic-co-glycolic acid)/β-tricalcium phosphate thin membrane using solid freeform fabrication technology for guided bone regeneration10.1089/ten.tea.2011.0730 ↗
11. A multiphase system bone implant for regenerating the calvaria10.1097/00006534-199304000-00002 ↗
12. A high-strength biodegradable thermoset polymer for internal fixation bone screws: preparation, in vitro and in vivo evaluation10.1016/j.colsurfb.2019.110445 ↗
13. Biodegradable polymers as biomaterials10.1016/j.progpolymsci.2007.05.017 ↗
14. Ultra‐high‐strength absorbable self‐reinforced polyglycolide (SR‐PGA) composite rods for internal fixation of bone fractures: in vitro and in vivo study10.1002/jbm.820250102 ↗
15. Orthopaedic applications for PLA-PGA biodegradable polymers10.1016/S0749-8063(98)70099-4 ↗
16. Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review10.1016/S0142-9612(00)00129-0 ↗
17. Synthetic biodegradable polymers as orthopedic devices10.1016/S0142-9612(00)00101-0 ↗
18. Synthesis and characterization of biomimetic citrate‐based biodegradable composites10.1002/jbm.a.34928 ↗
19. Synthesis and evaluation of poly (diol citrate) biodegradable elastomers10.1016/j.biomaterials.2005.05.106 ↗
20. A citric acid-based hydroxyapatite composite for orthopedic implants10.1016/j.biomaterials.2006.07.042 ↗
21. Effect of citric acid on the nucleation of hydroxyapatite in a simulated body fluid10.1016/S0142-9612(99)00118-0 ↗
22. Long-term in vivo response to citric acid-based nanocomposites for orthopaedic tissue engineering10.1007/s10856-011-4393-5 ↗
23. Strongly bound citrate stabilizes the apatite nanocrystals in bone10.1073/pnas.1009219107 ↗
24. Immediate bone forming capability of prefabricated osteogenic hydroxyapatite10.1002/(SICI)1097-4636(199611)32:3<481::AID-JBM23>3.0.CO;2-I ↗
25. The role of hydroxyapatite in citric acid-based nanocomposites: surface characteristics, degradation, and osteogenicity in vitro10.1016/j.actbio.2011.07.001 ↗
26. Development of osteopromotive poly (octamethylene citrate glycerophosphate) for enhanced bone regeneration10.1016/j.actbio.2019.03.050 ↗
27. Citrate‐based tannin‐bridged bone composites for lumbar fusion
28. Early tissue response to citric acid–based micro‐and nanocomposites10.1002/jbm.a.32953 ↗
29. Measurement and analysis of extracellular acid production to determine glycolytic rate10.3791/53464 ↗
30. Acidic extracellular microenvironment and cancer10.1186/1475-2867-13-89 ↗
31. Citrate-based materials fuel human stem cells by metabonegenic regulation10.1073/pnas.1813000115 ↗
32. The citric acid content of animal tissues, with reference to its occurrence in bone and tumour10.1042/bj0351011 ↗
33. Development of osteopromotive poly (octamethylene citrate glycerophosphate) for enhanced bone regeneration10.1016/j.actbio.2019.03.050 ↗
34. Synthesis and characterization of biomimetic citrate‐based biodegradable composites10.1002/jbm.a.34928 ↗
35. Citrate-based materials fuel human stem cells by metabonegenic regulation10.1073/pnas.1813000115 ↗
36. Novel citric acid‐based biodegradable elastomers for tissue engineering10.1002/adma.200306264 ↗
37. Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements10.1074/jbc.M116.774471 ↗
38. The contributions of respiration and glycolysis to extracellular acid production10.1016/j.bbabio.2014.10.005 ↗
39. Dysregulation of astrocytic mitochondrial function following exposure to a dopamine metabolite: implications for Parkinson's disease10.1111/ejn.14764 ↗